Development and validation of a clinical prognostic model for BRAF V600E-mutated colorectal cancer patients based on pathological stage, microsatellite status, and primary tumor site
By adding microsatellite status and primary tumor site on the basis of pathological stage, we improved the discriminability and prediction accuracy of the model and successfully established a prognosis model for patients with BRAF V600E mutation of colorectal cancer.
Authors
- Kai Ou (ORCID: https://orcid.org/0000-0003-2762-6719)
- Xiaoting Ma (ORCID: https://orcid.org/0000-0003-1329-9761)
- Xiu Liu (ORCID: https://orcid.org/0000-0001-7818-8312)
- Lin Yang (ORCID: https://orcid.org/0000-0002-7376-4082)
Institutions
- Chinese Academy of Medical Sciences & Peking Union Medical College (CN)
Publication Details
- Journal
- Frontiers in Oncology
- Published
- 2024-10-11
- DOI
- https://doi.org/10.3389/fonc.2024.1461237
- Citations
- 1
- Primary Topic
- Colorectal Cancer Treatments and Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.28
Funders
- Bethune Charitable Foundation
- Chinese Academy of Medical Sciences
- Wu Jieping Medical Foundation